SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jack w garnes jr. who wrote (5236)2/2/1998 10:31:00 PM
From: Tunica Albuginea  Read Replies (1) of 23519
 
Jack Re: HVSFapproval:

Difficulty in approving:
Message 3317189

Post on actobatics HVSF intends to do to approve (impossible):
Message 3311189

Has no applicator patent( won't get one either ).

The merits of the form of Alprostadil ( which is same as the one in MUSE, except it's mixed in a different carrier called Liposomal substrate ) will not be significant or somebody would have financed it by now.
The reverse split is to counter the inflationary devaluation of their stock, gg: It's like Asia: they are now raising the interest rates
to make Asia attartive:HVSF is tryint to put 100 dimes together so it will look like a 10 dollar bill and induce somebody to feel better about throwing his money out the window.

TA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext